查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
光免疫療法的全球市場，各治療領域、各終端用戶、各地區:競爭、預測、機會 (2027年)
市場調查報告書
商品編碼
1131715

光免疫療法的全球市場，各治療領域、各終端用戶、各地區:競爭、預測、機會 (2027年)

Global Photoimmunotherapy Market By Therapeutic Area, By End User, and By Region, Competition Forecast and Opportunities, 2027
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球光免疫療法市場，在預測期間內 (2023年～2027年) 預計目擊強勁的年複合成長率。

全球癌症罹患率增加，醫療費增加，為發現新癌症治療方法的研究開發 (R&D) 活動的進展等要素，牽引市場需求。還有醫療基礎設施整備和僱用熟練的醫護人員的主要機關的投資增加，政府的有利償付政策，成為能加速今後5年光免疫療法全球市場成長的其他顯著的要素。

本報告提供全球光免疫療法的市場相關分析，整體市場規模趨勢預測和市場佔有率結構 (各治療領域、各終端用戶)，各地區、主要國家詳細趨勢，主要的推動及阻礙市場要素，企業間的市場競爭結構，主要企業的簡介，今後的市場成長的方向性等調查。

目錄

第1章 產品概要

第2章 分析方法

第3章 摘要整理

第4章 COVID-19對全球光免疫療法市場的影響

第5章 客戶方面的見解

  • 治療的意識
  • 癌症的盛行率:男女
  • 癌症的盛行率:各年齡層
  • 癌症的盛行率:各地區

第6章 臨床實驗分析

第7章 專利分析

第8章 全球光免疫療法市場:未來展望

  • 市場規模與其預測
    • 以金額為準
  • 市場佔有率與其預測
    • 各治療領域 (頭頸椎癌症，轉移性黑色素瘤，其他)
    • 各終端用戶 (醫院、診療所，門診病人治療中心，生物科技、製藥公司，其他)
    • 各企業 (2021年)
    • 各地區
  • 產品市場地圖

第9章 北美的光免疫療法市場預測

  • 市場規模與其預測
  • 市場佔有率與預測
    • 各治療領域
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國的光免疫療法市場預測
    • 墨西哥的光免疫療法市場預測
    • 加拿大的光免疫療法市場預測

第10章 歐洲的光免疫療法市場預測

  • 市場規模與其預測
  • 市場佔有率與預測
  • 歐洲:各國分析
    • 法國的光免疫療法市場預測
    • 德國的光免疫療法市場預測
    • 英國的光免疫療法市場預測
    • 義大利的光免疫療法市場預測
    • 西班牙的光免疫療法市場預測

第11章 亞太地區的光免疫療法市場預測

  • 市場規模與其預測
  • 市場佔有率與預測
  • 亞太地區:各國分析
    • 中國的光免疫療法市場預測
    • 印度的光免疫療法市場預測
    • 韓國的光免疫療法市場預測
    • 日本的光免疫療法市場預測
    • 澳洲的光免疫療法市場預測

第12章 南美的光免疫療法市場預測

  • 市場規模與其預測
  • 市場佔有率與預測
  • 南美:各國分析
    • 巴西的光免疫療法市場預測
    • 阿根廷的光免疫療法市場預測
    • 哥倫比亞的光免疫療法市場預測

第13章 中東、非洲的光免疫療法市場預測

  • 市場規模與其預測
  • 市場佔有率與預測
  • 中東、非洲:各國分析
    • 南非的光免疫療法市場預測
    • 沙烏地阿拉伯的光免疫療法市場預測
    • 阿拉伯聯合大公國的光免疫療法市場預測

第14章 市場動態

  • 促進因素
  • 課題

第15章 市場趨勢和動靜

第16章 競爭情形

  • Rakuten Medical, Inc.
  • Shimadzu Corporation
  • Modulight Corporation
  • Steba Biotech Ltd.
  • Luzitin SA

第17章 策略性建議

簡介目錄
Product Code: 12819

The global photoimmunotherapy market is anticipated to witness robust CAGR in the forecast period, 2023-2027. Factors such as the increasing prevalence of cancer worldwide, growing healthcare expenditure, and ongoing research and development activities to find novel cancer treatment therapies primarily drive the demand for the global photoimmunotherapy market. The rise in the investments by the leading authorities to develop the healthcare infrastructure and hire skilled healthcare professionals and favorable government reimbursement policies are the other prominent factors that can accelerate the global photoimmunotherapy market growth over the next five years.

Increased Cancer Prevalence Worldwide Drives the Market Growth

Cancer is a major health concern and is a leading cause of death across the globe. According to World Health Organization, cancer accounted for nearly 10 million deaths in 2020. During cancer, there is the rapid creation of abnormal cells that grow beyond their usual boundaries and can invade the adjoining parts of the body and spread to other organs, and the process is called metastasis. Some of the most common kinds of cancer are breast, lung, colon, rectum, and prostate cancers. In 2020, due to lung cancer, around 1.0 million deaths were observed. Similarly, for colon and rectum and liver cancer, the number of deaths in 2020 was 916000 and 830000. Adoption of an unhealthy and sedentary lifestyle, high body mass index, high alcohol, and tobacco consumption, and low fruit and vegetable intake are the main cancer-causing factors. Approximately 400 000 children develop cancer every year, and cervical cancer is the most common cancer in 23 countries. Cancer can be reduced through early detection and the right treatment and care of the patients. The majority of cancers can be cured if detected and treated early. Photoimmunotherapy is the recently developed hybrid cancer therapy that directly kills cancer cells as well as produces a therapeutic host immune response. Conventional immunotherapies such as checkpoint inhibition, engineered T cells and suppressor cell depletion, and immune-activating cytokine therapy do not directly destroy the cancer cells and rely on activating the immune system. Photoimmunotherapy selectively destroys the cancer cells, which releases cancer antigens from dying cancer cells. Therefore, the increased cancer incidence worldwide and the high mortality rate due to cancer are expected to bolster the global photoimmunotherapy market growth over the forecast period.

Favorable Government Policies Supports the Market Growth

The government of various countries are concerned with the growing number of cancer cases and are taking steps to lower the patient mortality rate due to cancer. They are providing financial support, reimbursing the cost incurred during the cancer treatment procedures, and funding cancer treatment research and development activities, among others. For instance, in India, some of the steps taken by the government that can fund cancer treatment are Health Minister's Cancer Patient Fund, The Health Minister's Discretionary Grants, The Central Government Health Scheme (CGHS), National Health Protection Scheme and The Prime Minister's National Relief Fund. Leading authorities of various countries are also promoting the adoption of novel technologies to treat cancer effectively. Massive support from the governments is making the market players invest and find new solutions for cancer treatment. Therefore, supportive government policies and the entry of new market players are expected to play a major role in boosting the global photoimmunotherapy market growth over the next five years.

Market Segmentation

The global photoimmunotherapy market is segmented into therapeutic area, end user, regional distribution, and competitive landscape. Based on therapeutic area, the market is divided into head & neck cancer, metastatic melanoma, and others. Based on end user, the market is divided into hospitals & clinics, ambulatory care centers, biotechnology & pharmaceutical companies, and others. The market analysis also studies the regional segmentation, which is divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region. In terms of country, the United States is expected to hold a significant market share due to the early adoption of advanced technologies by the healthcare sector and the presence of major market players in the country.

Market Players

Rakuten Medical, Inc., Shimadzu Corporation, Modulight Corporation, Steba Biotech Ltd., Luzitin SA are the major market players operating in the global photoimmunotherapy market.

Report Scope:

In this report, global photoimmunotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Photoimmunotherapy Market, By Therapeutic Area:

  • Head & Neck Cancer
  • Metastatic Melanoma
  • Others

Photoimmunotherapy Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Biotechnology & Pharmaceutical Companies
  • Others

Photoimmunotherapy Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global photoimmunotherapy market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Photoimmunotherapy Market

5. Voice of Customer

  • 5.1. Therapy Awareness
  • 5.2. Cancer Prevalence, By Gender
  • 5.3. Cancer Prevalence, By Age Group
  • 5.4. Cancer Prevalence, By Region

6. Clinical Trial Analysis

7. Patent Analysis

8. Global Photoimmunotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapeutic Area (Head & Neck Cancer, Metastatic Melanoma, Others)
    • 8.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Biotechnology & Pharmaceutical Companies, Others)
    • 8.2.3. By Company (2021)
    • 8.2.4. By Region
  • 8.3. Product Market Map

9. North America Photoimmunotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapeutic Area
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Photoimmunotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapeutic Area
        • 9.3.1.2.2. By End User
    • 9.3.2. Mexico Photoimmunotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapeutic Area
        • 9.3.2.2.2. By End User
    • 9.3.3. Canada Photoimmunotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapeutic Area
        • 9.3.3.2.2. By End User

10. Europe Photoimmunotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapeutic Area
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. Europe: Country Analysis
    • 10.3.1. France Photoimmunotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapeutic Area
        • 10.3.1.2.2. By End User
    • 10.3.2. Germany Photoimmunotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapeutic Area
        • 10.3.2.2.2. By End User
    • 10.3.3. United Kingdom Photoimmunotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapeutic Area
        • 10.3.3.2.2. By End User
    • 10.3.4. Italy Photoimmunotherapy Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Therapeutic Area
        • 10.3.4.2.2. By End User
    • 10.3.5. Spain Photoimmunotherapy Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Therapeutic Area
        • 10.3.5.2.2. By End User

11. Asia-Pacific Photoimmunotherapy Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapeutic Area
    • 11.2.2. By End User
    • 11.2.3. By Country
  • 11.3. Asia-Pacific: Country Analysis
    • 11.3.1. China Photoimmunotherapy Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapeutic Area
        • 11.3.1.2.2. By End User
    • 11.3.2. India Photoimmunotherapy Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapeutic Area
        • 11.3.2.2.2. By End User
    • 11.3.3. South Korea Photoimmunotherapy Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapeutic Area
        • 11.3.3.2.2. By End User
    • 11.3.4. Japan Photoimmunotherapy Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Therapeutic Area
        • 11.3.4.2.2. By End User
    • 11.3.5. Australia Photoimmunotherapy Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Therapeutic Area
        • 11.3.5.2.2. By End User

12. South America Photoimmunotherapy Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Therapeutic Area
    • 12.2.2. By End User
    • 12.2.3. By Country
  • 12.3. South America: Country Analysis
    • 12.3.1. Brazil Photoimmunotherapy Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Therapeutic Area
        • 12.3.1.2.2. By End User
    • 12.3.2. Argentina Photoimmunotherapy Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Therapeutic Area
        • 12.3.2.2.2. By End User
    • 12.3.3. Colombia Photoimmunotherapy Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Therapeutic Area
        • 12.3.3.2.2. By End User

13. Middle East and Africa Photoimmunotherapy Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Therapeutic Area
    • 13.2.2. By End User
    • 13.2.3. By Country
  • 13.3. MEA: Country Analysis
    • 13.3.1. South Africa Photoimmunotherapy Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Therapeutic Area
        • 13.3.1.2.2. By End User
    • 13.3.2. Saudi Arabia Photoimmunotherapy Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Therapeutic Area
        • 13.3.2.2.2. By End User
    • 13.3.3. UAE Photoimmunotherapy Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Therapeutic Area
        • 13.3.3.2.2. By End User

14. Market Dynamics

  • 14.1. Drivers
  • 14.2. Challenges

15. Market Trends & Developments

16. Competitive Landscape

  • 16.1. Rakuten Medical, Inc.
  • 16.2. Shimadzu Corporation
  • 16.3. Modulight Corporation
  • 16.4. Steba Biotech Ltd.
  • 16.5. Luzitin SA

17. Strategic Recommendations